Clinical Trials Browser

Phase 1 × Lymphoma × durvalumab × Clear all

NCT03739931 2025-08-15

Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies

Phase 1 Completed

Head & NeckLymphoid

Squamous Cell Carcinoma of Head and Neck, Lymphoma

NCT02793466 2023-09-22

Durvalumab in Pediatric and Adolescent Patients

Phase 1 Completed

Lymphoma, Central Nervous System Neoplasms